Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced today that it has completed the sale of certain assets related to its hemofiltration product line to Baxter International Inc., consistent with the previously announced terms of the agreement.
Edwards Lifesciences completes sale of hemofiltration product line